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Maximum ultrafiltration rates during peritoneal dialysis in rats. It has
been suggested that filtration pressure equilibrium could occur in
peritoneal capillaries during peritoneal dialysis with very hypertonic
exchanges. Rats were exposed to peritoneal dialysis solutions using 16
ml instillations, 30 minute cycles, and dextrose concentrations from 1.4
to 20 g%. There was a plateau in ultrafiltration per exchange at mean
osmotic gradients above 360 mOsm/kg H20 near 12.5 mI/ex (0.42
mi/mm). The findings are also compatible with filtration pressure
equilibrium predictions at an effective capillary plasma flow of 0.84
mI/mm and a filtration fraction near 50%. Studies with cardiovascular
drugs (norepinephrine Lv., nitroprusside i.p., and dobutamine i.v.)
showed no effects on the maximum ultrafiltration rates. This might
indicate that flow is rather fixed because of known microcirculatory
effects of solutions themselves.
Filtration pressure equilibrium may occur in glomerular cap-
illaries of some species [1]. In glomerular capillaries with
adequate filtration fractions, increasing oncotic pressure along
the capillaries may eventually equal net transcapillary hydrau-
lic—pressure, preventing additional ultrafiltration. Since glomer-
ular filtrate is very low in protein and is an ultrafiltrate of serum,
there is little or no contribution to transmembrane osmotic
pressure other than plasma protein oncotic—pressure.
In Contrast, in peritoneal dialysis, an osmotic agent, usually
glucose, is added to the dialysis solution to generate ultrafil-
trate. We have previously summarized evidence to support the
hypothesis that the major source of the ultrafiltrate is blood
from peritoneal capillaries [2—41.
Ronco and colleagues have suggested that ultrafiltration rates
per exchange during peritoneal dialysis should be limited at
very high mean osmotic gradients by steep increases in plasma
oncotic pressure as plasma filtration fraction approaches 50%
[5]. Attempts to increase filtration fraction further by increasing
mean osmotic pressure would result in little or no increase in
filtration rate since oncotic pressure increases sharply with only
small increments in filtration fraction. At lower mean osmotic
pressures and filtration fractions, ultrafiltration per exchange
might be limited by capillary pore area, hydraulic permeability,
and/or filtration pressure equilibrium. Increments in mean os-
motic gradient would increase ultrafiltration and filtration frac-
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tions regardless of which were most limiting as long as filtration
fractions were below 40 to 50%.
The main purpose of these studies was to measure ultrafiltra-
tion rates in rats undergoing peritoneal dialysis exchanges at
fixed instillation volumes and cycle times with progressive
increases in dialysis-solution glucose concentration to levels
well above those that are used clinically. An ultrafiltration
maximum is shown to be demonstrable. Effects of intravenous
and intraperitoneal vasoactive agents on this ultraffitration
maximum were assessed. Our findings raise questions about the
magnitude of effective, peritoneal capillary blood—flow relative
to the peritoneal dialysis process.
Methods
Studies in rats
The animal model. Sprague—Dawley male rats, 290 to 375 g,
were anesthetized with 50 mg/kg of subcutaneous Nembutal
solution (Abbott Laboratories, North Chicago, Illinois, USA).
Rats were placed supine on a heating pad at 37°C and body
temperature was monitored with a rectal temperature probe
(Yellow Springs Instruments, Inc., Model 402). The external
jugular vein was exposed and cannulated for intravenous ad-
ministration. Blood pressure was monitored through a cannula
in the femoral artery with a pressure transducer (P 23/D, Gould
Statham, Hato Rey, Puerto Rico) connected to a polygraph
(Low—Level D.C. Preamplifier in a Grass Instruments Co.,
Model 7 Polygraph, Grass Instruments Co., Quincy, Massachu-
setts, USA). A continuous electrocardiogram was recorded
using subcutaneous electrodes with an EKG-Pulse preamplifier
in a Model 7 polygraph (Grass Instruments Co.). Heart rate was
measured from the electrocardiogram.
An indwelling peritoneal catheter was placed through a
midline incision 1 cm below the xiphoid process. A Tenckhoff
type catheter was advanced into the peritoneal cavity with the
tip in the right lower quadrant of the abdomen.
The animals were hydrated through the venous cannula with
warmed lactated Ringers solution (Baxter—Travenol Company,
Deerfield, Illinois, USA). The infusion rate was maintained at
8.8 to 13.3 mI/hr with a syringe pump (Sage Instruments, Model
341). Peritoneal exchanges were not begun until each rat was
undergoing diuresis (90 to 120 mm after the i.v. infusion was
begun). The infusion rate was chosen to replace fluid losses due
to peritoneal ultrafiltration (UF), and to maintain the rats in an
expanded, diuretic state.
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Dialysis solutions. The peritoneal dialysis solution used was
Travenol Dianeal PD-2 containing sodium 132 mEq/liter, cal-
cium 3.5 mEq/liter, magnesium 0.5 mEq/liter, chloride 96
mEq/liter, lactate 40 mEq/liter and 1.5% or 4.25%monohydrous
dextrose. The actual anhydrous glucose concentrations in these
solutions are 1.36 and 3.86%. Additional dextrose was added to
the solutions for exchanges with higher dextrose concentra-
tions. Anhydrous powder was added to achieve total anhydrous
concentrations as shown. All dialysis solutions were adjusted to
a pH of 7.4 with 1.0 N sodium hydroxide.
Peritoneal dialysis protocol. After commencement of diure-
sis, blood was drawn from the tail vein to obtain serum
osmolality and hematocrit prior to any exchanges. After a five
minute wash—out with 1.5% Dianeal (pH 7.4), 16 ml of dialysis
solution with dextrose concentration as per protocol were
infused into the peritoneum in approximately 15 seconds. The
solution was allowed to dwell in the peritoneal cavity for 25
minutes, after which drainage was performed over a five minute
period. The total cycle time was 30 minutes. Drainage was by
gravity only, with slight manual agitation of the abdomen.
Sacrifice and direct aspiration of residual fluid have revealed
residual volumes near I ml with this technique, Since even very
large molecular size volume markers are absorbed by rat
lymphatics [6], mechanical drainage may be as accurate. At the
end of each exchange, blood hematocrit was measured.
Protocols consisted of a series of exchangcs (usually 4 to 7)
with varying dextrose concentrations. Exchanges were re-
peated with progressive increments in dextrose concentration
in six rats. Fourteen rats underwent a series of exchanges at a
fixed dialysis solution glucose concentration of 15% (10), 6%
(2), 1.4% (2) respectively. Prior to exchanges, serum glucose
concentration was measured using Chemstrip BG (Boehringer
Mannheim Diagnostic, Inc., Indianapolis, Indiana, USA). In-
sulin was added to peritoneal dialysis solutions (0.1 units of
pork insulin/g% dextrose) and intravenously as necessary to
maintain serum glucose at 200 mg% or less.
Specialstudies. Six animals underwent exchanges with 15 g%
dextrose at a reduced instillation volume of 10 ml. The purpose
of this study was to assess the effects of instillation volume on
maximum ultrafiltration rate.
In two rats dextrose concentrations were decreased from two
exchanges with 20% dextrose to two exchanges with 3.9%
dextrose.
Six rats had consecutive 15% dextrose exchanges with total
cycle times of 15 and 25 minutes (10 and 15 mm dwells); the
order was alternated. These studies were to see if net UF was
proportional to cycle time at the maximum rate.
Seven rats were exposed to 5, 10, 15, and 20% dextrose
exchanges at 15 minute total cycle times (10 minute dwells) to
see if a maximum net UF per exchange could be demonstrated
at short cycle times and lower net UF volumes, but at the
maximum rate of UF seen with longer cycles, in three rats,
consecutive exchanges went from low to high dextrose; in four,
from high to low.
Two animals underwent a series of 16 ml exchanges with 15
g% dextrose; after control exchanges, nitroprusside (4.5 mgI
liter) was added to the instilled solution. Five animals under-
went exchanges with 15 g% dextrose and 16 ml volumes; after
control exchanges, norepinephrine was infused intravenously
(0.3 g/kgImin). Three animals underwent studies with 16 ml, 15
g% dextrose exchanges; after control exchanges, Dobutamine
was instilled intravenously (5.0 g/kg/min). For each animal,
single mean values of ultrafiltration were calculated for control
and for drug associated exchanges.
Laboratory instruments. Osmolalities were measured in dial-
ysate solutions before and after each exchange and in serum
samples as above, using a Wescor 5100 B vapor pressure
osmometer (Wescor Inc., Logan, Utah, USA). Concentrations
of sodium were determined with a flame photometer (Model
343, Instrumentation Laboratories, Inc., Lexington, Massachu-
setts, USA).
Histology. Following completion of the exchange protocol,
animals were sacrificed and tissue samples were taken from the
abdominal wall, intestine and mesentery, to see if mesothelial
alterations secondary to the exposure to the hypertonic solu-
tions were detectable. The tissues were prepared for light
microscopy with "en face" silver staining and mounted as
previously described [7].
Statistics and calculations
Net ultrafiltration per exchange was calculated as drainage
volume minus instillation volume. In studies with cardiovascu-
lar drugs, mean values of net ultrafiltration per exchange, mean
blood pressure, and mean heart rate with control and drug
associated exchanges were compared by the paired Student's
f-test. The mean osmotic gradient during an exchange (mOsm/
kg H20) was calculated as the average of dialysate minus serum
osmolality at the beginning and at the end of the exchange. Net
sodium removal per liter of net ultrafiltration was related to
serum sodium calculated as (sodium concentration in instilled
solution x the instilled volume)—(sodium concentration in
drainage x the drainage volume)/net ultrafiltration/mean serum
sodium concentration from 10 control rats {8].
Results
Overall, mean serum osmolality in 19 rats at the beginning of
experiments was 289 mOsm/kg H20 10 SEM, and mean serum
osmolality at the end of experiments was 331 31. This most
likely reflects some rise in serum glucose and some increase in
serum sodium concentration related to the net sodium sieving
effects of peritoneal ultrafiltration [8, 9]. This small rise had
little effect on the osmotic gradient. Mean hematocrit at the
beginning of studies was 44 0.6 (N = 24) and the end of
studies was 45 1.1 (N 17). Heart rates and blood pressures
were stable except for nitroprusside studies mentioned below.
Table I summarizes the effects of dextrose concentration in
dialysis solution on net ultrafiltration per exchange. The Table
shows the number of animals subjected to each type of ex-
change. In those animals undergoing more than one exchange
with a given dextrose concentration, a single mean value per
animal was used. Mean values for solutions above 8 g%
dextrose suggest a plateau in ultrafiltration per exchange.
Ultrafiltration rate based on total cycle time at maximum
averaged 0.42 mI/mm.
Figure 1 shows results from studies in six rats where there
were progressive increases in dialysis solution dextrose—
concentrations and mean osmotic gradients over a series of
exchanges up to seven exchanges. Increases in net ultrafiltra-
tion (UF) per exchange are seen with increases in mean osmotic
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gradient to 240 mOsm/kg. Thereafter, there appears to be a
plateau or reduction in the increments.
Figure 2 shows the mass plot of all net UF measurements per
exchange in all rat studies. This includes studies from rats that
underwent serial exchanges at the same or decreasing dextrose
concentrations in dialysis solution for consecutive exchanges.
Points fall close to the same ranges of UF per exchange at any
given osmotic gradient as in Figure 1. In any single rat experi-
ment, net UF per exchange usually fell in the same range for
given dextrose concentrations.
Figure 3 shows the typical appearance of mesentery in rats
subjected to these experiments. Mesothelial boundaries were
still intact, no mesothelial denudation or injury was apparent.
As net ultrafiltration per exchange increased, above 12
mI/exchange, the net removal of water was accompanied by
relatively low amounts of sodium compared to extracellular
fluid and yielded ratios of net sodium removal per liter of UF













16 15 12.5 0.3 0.78 0.02
10 6 8.0 0.7 0.80 0.07
V,, instilled volume
effect has been well recognized as characteristic of peritoneal
ultrafiltration and is maintained under the conditions of these
studies [9].
Table 2 shows the results in animals subjected to exchanges
at 15 g% dextrose with 10 ml instillation volumes, as compared
to those in animals with 16 ml instillation volumes. The ratio of
net ultrafiltration to the instilled volume remains unchanged.
Similar high mean time averaged osmotic gradients were main-
Table 1. Effects of increasing dextrose concentration, (mean 5EM)
Dextrose N Gradienta UFb
gIdI animals mOsm/kg mi/exchange
1.4 6 35±3 2.4±0.6
3.0 4 86 10 5.3 0.3
3.9 4 125 6 6.2 0.1
6.0 10 186 10 7.4 0.5
8.0 7 262 15 9.9 0.5
9.0 2 330 8 11.0 1.0
10.0 4 344 32 10.6 0.8
15.0 16 488 12 12.2 0.4








b Means using one value per rat, thus a mean of means with N and












Fig. 1. Ultrafiltration (UF) is related to the mean time averaged
osmotic gradient during each exchange. In these studies, progressive
increases in dextrose were used during a series of exchanges. Symbols
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Osmotic gradient, mOsm/kg
Fig. 2. Mass plot of UF measurements from all exchanges using 16 ml
instilled volumes without cardiovascular drugs are related to the mean
time averaged osmotic gradient.
Fig. 3. En face silver stain of visual mesentery from a rat exposed to
15% dextrose exchanges. Mesothelial cell boundaries appear intact.
(magnification 110 x)
Table 2. Effect of VIN at dextrose, 15 g/dl (mean 5EM)
120 240 360 480 600
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Varied short cycle times
15 15 7.6 1.2 0.51 6
25 15 10.9 1.2 0.43 6
Varied dextrose at fixed short cycle time
15 5 3.5 0.7 0.23 7
15 10 5.6 0.4 0.37 7
15 15 6.7 0.6 0.45 7
15 20 5.6 0.5 0.37 7
Table 3. UF with shorter cycle times (mean SEM) Increases in lymphatic reabsorption rates could be important in
UF rat
- limiting maximum net ultrafiltration.
mi/mm animals It seems unlikely that increases in peritoneal fluid hydraulic
pressure explain the limitations on ultrafiltration per exchange
that we observed. Net ultrafiltration per exchange was propor-
tionally reduced with low instillation volumes. With low vol-
umes, mean osmotic gradient was still very high throughout the
exchange and the reduced net ultrafiltration might represent
primarily—reduced fluid membrane contact and reduced mem-
brane surface exposed to the osmotic gradient. Solute clear-
ances have been previously reported to be proportional to
instillation volume [121. If i.p. hydraulic pressure had signifi-
cantly limited ultrafiltration per exchange at higher volumes, it
would seem reasonable that the ratio of net ultrafiltration to
______ ____________________________________
instilled volume would not remain constant, but increase, as the
i.p. hydraulic pressure was maintained lower. Also, the rats did
not appear to develop tense ascites, not did changes in their
vital signs suggest hemodynamic alternations that might be
anticipated with respiratory compromise. Perhaps even more
importantly, similar maximum UF rates were seen with shorter
cycles and lower intraperitoneal volumes.
We cannot quantitate the possible magnitude of concentra-
tion polarization effects in the rat peritoneal circulation, but
such effects must be considered [131.
Accurate assessment of osmotic pressures during peritoneal
dialysis is not possible. The reflection coefficient for glucose has
been indirectly measured in humans at 0.38 [14].
The average maximum ultrafiltration per 30 minute exchange
in the rat was 12.5 ml, which averages over the exchange to be
0.42 mI/mm. Instantaneous ultrafiltration rates would be highest
at the beginning of the exchange and decreases due to glucose
absorption [15]. However, with 30 minute cycles at very high
osmotic gradients, ultrafiltration rate was relatively fixed when
the osmotic gradient was maintained above that needed to
induce maximum ultrafiltration. If 0.42 mI/mm is the maximum
average ultrafiltration rate possible with these cycle times and
volumes due to filtration pressure equilibrium, and if indeed
maximum filtration fraction is near 50%, as predicted by Ronco
and colleagues [5], then effective capillary plasma—flow would
be in the range of 0.84 mI/mm. Using an average end—experi-
ment hematocrit value of 45%, effective blood flow would be
calculated as 0.84/0.55 = 1.5 mllmin. Such calculations of blood
flow might be erroneous if sieving of electrolytes at the mem-
brane interfaces exaggerates concentration polarization. In
other studies, using 1.5% dextrose solutions yielding low ultra-
filtration (1.2 mI/exchange), mean urea clearances were found
to be 0.45 0.01 SEM mI/mm in 15 exchanges from five rats [16].
CO2 diffusion into peritoneal dialysis solutions in humans [3]
and hydrogen gas absorption from peritoneal dialysis solutions
in rabbits [17] have suggested that mass—transfer area coeffi-
cients for these gases are estimates of effective blood flow and
are two to three times urea clearances. Predictions of effective
blood flow in our rat model as two to three times urea clearance
measurements would predict 0.90 to 1.35 mI/mm. The high
value is near that estimated above from principles of filtration
pressure equilibrium (1.5 ml/min).
There is no evidence that the very hypertonic exchanges
caused major morphological or functional changes in the pen-
toneal membrane. Net ultrafiltration per exchange could be
maintained at high levels, and decreases in osmotic gradient










N ml exchange SEM
Concentration animals Control With agent
4.5 mg/liter (i.p.) 2 12.9 0.1 12.4 0.9
0.3 mcg/kglmin (i.v.) 5 13.5 0.2 12.9 0.5
5.0 meg/kg/mm (i.v.) 3 13.0 1,0 12.0 1.2
tamed (490 8 and 488 12 mOsm/kg H2O with 10 ml and 16
ml exchanges, respectively); however, there may have been
less fluid membrane contact proportional to volume as sug-
gested by the fixed ratio.
When shorter cycles were used, there was also a plateau of
UP rates (Table 3). At dextrose concentrations of 10% or
higher, UF ranged from 0.37 to 0.51 mllmin (mean 0.43) which
is comparable to that achieved with the longer cycles.
With 15% dextrose exchanges, UF rates were not signifi-
cantly different with 15' and 25' cycles in the paired studies.
Table 4 shows the results in animals subjected to a series of
exchanges with 15 g% dextrose while receiving i.p. or i.v.
agents selected to alter peritoneal capillary blood—flow. Mean
values from the drug studies showed no significant differences
from mean values of ultrafiltration per exchange at the same
dextrose concentration without drug exposure. There were no
significant changes with drug administration except for a signif-
icant increase in heart rate with nitroprusside from 421 to 443 (P
< 0.01). Other transient alterations in heart rate and blood
pressure included bradycardia with norepinephrine, increased
blood pressure with norepinephrine, and lowered blood pres-
sure with nitroprusside.
Discussion
Our findings demonstrate a net ultrafiltration maximum at
high osmotic pressure gradients in rats undergoing peritoneal
dialysis cycles. Additional studies will be needed to determine
if this represents filtration pressure equilibrium.
We have previously reviewed evidence that most of the
peritoneal ultrafiltration represents an ultrafiltrate of peritoneal
capillary blood [2—4]. However, recently proposed models of
penitoneal transport emphasize the complexities related to
solute and water distribution in tissues [10, 11]. Possible par-
ticipation of lymphatics cannot be excluded [6, 10, 11].
Any lymphatic absorption would reduce net ultrafiltration
and actual transcapillary ultrafiltration may be underestimated.
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with subsequent exchanges caused decreases in UF as ex-
pected. The sodium sieving effects support the integrity of the
peritoneal membrane. We have previously explored possible
mechanisms for electrolyte sieving during peritoneal dialysis [8,
9, 181. None of these mechanisms would be expected to persist
in the face of an injured membrane.
Perhaps most disconcerting to the filtration pressure equilib-
rium hypothesis is the lack of effect of drugs which were chosen
to manipulate effective peritoneal capillary—flow. However, we
have no direct proof that drugs changed effective peritoneal
capillary—flow. Hypertonicity itself has been shown to be
vasodilatory, as has lactate [4, 19—22]. There is good evidence
that nitroprusside causes increases in venular permeability at
the doses used, but it may not induce any greater arteriolar
vasodilation of the microcirculation than the solutions them-
selves [4, 19, 21]. Increases in venular permeability might alter
the reflection coefficient for glucose and reduce the effective
osmotic pressure. Norepinephrine was used at a dose previ-
ously shown to reduce urea clearances [23]; since urea clear-
ances are not usually thought to be blood flow limited, this
would represent substantial reductions in the effective capillary
flow. However, another animal model was used.
In summary, our findings in vivo are compatible with the
possibility that maximum ultrafiltration primarily reflects the
limitations of effective peritoneal capillary blood—flow and
filtration pressure equilibrium. Additional studies are required
to confirm this.
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